List of Field Safety Notices from 20 to 24 April 2026.
Category archives: Uncategorized
Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21
Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the Carton in packs of Napralief 250mg…
Field Safety Notices: 13 to 17 April 2026
List of Field Safety Notices from 13 to 17 April 2026.
Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20
Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of certain parallel imported batches of Hiprex 1 g tablets (POM).
Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 10mg capsules, EL(26)A/19
Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site.
Field Safety Notices: 6 to 10 April 2026
List of Field Safety Notices for 6 to 10 April 2026.
Field Safety Notices: 30 March – 3 April 2026
List of Field Safety Notices for 30 March – 3 April 2026
MHRA Safety Roundup: March 2026
Summary of the latest safety advice for medicines and medical device users
Field Safety Notices: 23-27 March 2026
List of field Safety Notices for 23-27 March 2026
Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Injection, EL(26)A/18
Bio Products Laboratory Limited is recalling one batch of Human Rabies Immunoglobulin following a stability failure for this batch. The batch has shown a reduction in potency of the Human Rabies immunoglobulin.


